Affiliation:
1. Department of Korean Internal Medicine, College of Korean Medicine, Wonkwang University, 460, Iksan-daero, South Korea
2. Department of Diagnostics, College of Korean Medicine, Wonkwang University, 460, Iksan-daero, South Korea
3. Research Center of Traditional Korean Medicine, College of Korean Medicine, Wonkwang University 460, Iksan-daero, South Korea.
Abstract
Introduction:
The prevalence of cardiac arrhythmia, which can lead to cardiac death, heart failure, and cardioembolic stroke, is increasing. Although various Western medicines for cardiac arrhythmias have been developed, there are still various difficulties in the management of arrhythmias. Traditional herbal medicines (THM) are widely used to manage arrhythmia in East Asia. Therefore, this study aimed to assess the effectiveness and safety of THM in the treatment of arrhythmia.
Method:
Using a systematic review methodology, we searched for randomized clinical trials on herbal medicines for arrhythmia without complications in 4 databases up to September 2022. The literature search was carried out again, targeting papers published until April 2024.We conducted a risk-of-bias assessment and meta-analysis. This study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines.
Results:
Eighty-two randomized clinical trials were included in this meta-analysis. Total effective rate was significantly better in unspecified arrhythmia (risk ratio [RR]: 1.20, 95% confidence interval [CI]: 1.13–1.26), premature ventricular contraction (RR: 1.29, 95% CI: 1.29–1.33), sinus bradycardia (RR: 1.26, 95% CI: 1.17–1.36), tachycardia (RR: 1.23 95% CI: 1.15–1.32), and atrial fibrillation (RR: 1.17, 95% CI: 1.07–1.27). No severe adverse events were associated with THM. The overall risk of bias was relatively high. The total effective rate was the most frequently assessed clinical outcome variable. Most outcomes were surrogates and not clinical endpoints.
Conclusion:
THM, alone or in combination with Western medicine, has therapeutic effects on cardiac arrhythmic diseases. However, additional disease-specific clinical outcome variables are required for further studies on THM. Owing to the low quality of the included studies and their small sample sizes, additional large-scale, long-term follow-up, and well-designed randomized controlled clinical trials are required.
Systematic review registration number:
Details of the protocol for this systematic review and meta-analysis were registered on the Open Science Framework (OSF. io). (https://osf.io/7r8kn/).
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference97 articles.
1. One case of Bradyarrhythmia treated with (炙甘草湯) and acupuncture.;Yang;J Int Korean Med,2010
2. Mechanism of atrial fibrillation.;Jong;Korean J Med,2011
3. Overview of basic mechanisms of cardiac arrhythmia.;Antzelevitch;Card Electrophysiol Clin,2011
4. Evidence-based analysis of amiodarone efficacy and safety.;Connolly;Circulation,1999
5. Beta-blockers and outcome in heart failure and atrial fibrillation.;Rienstra;JACC Heart Fail,2013